A Comprehensive study of stress degradation pathways of Ascorbic acid to standardize Flavonoids-Related impurities derived from ascorbic acid
Abstract
Ascorbic acids are gaining popularity as functional food or health supplement owing to their antioxidant property. Ascorbic acid API or antioxidant ingredients was subjected to force degradation studies under various hydrolysis conditions as per the ICH guidelines i.e. acidic, alkaline, thermal, oxidative, and photolytic. The degraded samples were analyzed using a compatible self-developed HPLC method. The drug was found to be highly sensitive to alkaline environment and exhibited significant degradation. The drug has also shown degradation when exposed to oxidative stress. The drug was found to be quite stable in acidic, photolytic, and thermal conditions. The major degraded product obtained in alkaline condition was isolated, purified and characterized as (3S, 4R,5S)-3,4,5,6-tetrahydroxy-2-oxohexanoic acid with molecular mass of 194.14 g/mol and molecular formula of C6H10O7. This compound is a pharmacopeial impurity (EP impurity C) of the drug. This compound was then converted to its ester form to further ascertain its structural configuration. The ester was characterized as (3S, 4R, 5S)-methyl 3,4,5,6-tetrahydroxy-2-oxohexanoate (EP impurity D) with molecular mass of 208.17 g/mole and molecular formula of C7H12O7 The compounds were characterized with NMR, DMR, and mass spectroscopic technique. When ascorbic acid was subjected to oxidative stress, a water-soluble compound was obtained as the major degradant. Its isolation, identification and characterization are under study. A mechanism for the formation of (3S, 4R, 5S)-3,4,5,6-tetrahydroxy-2-oxohexanoic acid as the major degradant in alkaline stress was proposed.
Keywords:
Ascorbic acid, Pharmacopeial impurities, Degradation, HPLC, Esterification, Flavonoid-related compounds, AntioxidantDOI
https://doi.org/10.25004/IJPSDR.2024.160115References
Zehiroglu C, Sarikaya SBO. The importance of antioxidants and their place in today’s scientific and technological studies. J. Food. Sci. Technol. 2019; 56: 4757-4779.
Pedro AC, Paniz OG, Fernandes IAA, Bortolini DE, Rubio FTV, Haminiuk CWI, Maciel GM, Magalhaes LWE. The importance of antioxidant biomaterials in human health and technological innovation: A review. Antioxidants. 2022; 11(9): 1644.
Cherrak SA, Soulimane NM, Berroukeche F, Bensenane B, Cherbonnel A, Merzouk H, Elhabiri M. In Vitro Antioxidant versus metal ion chelating properties of flavonoids: A structure-activity investigation. PLOS. 2016; 11(10): e0165575.
Baldim JL, Vasconcelos de Alcantara BG, Domingois O, Soares MG, Caldas LS, Novaes RD, Oliveira TB, Lago JHG, Chagas-Paula DA. The correlation between chemical structures and antioxidant, prooxidant, and anti-trypanosomatid properties of flavonoids. Oxid. Med. cell. Longev. 2017.
Yadav J, Chaurasia M, Dubey BK. Flavonoids: A review on chemistry and versatile biological activity. EJMR. 2020; 7(1): 75-78. 10.24041/ejmr2020.13s
Neuza FGR, Mirele DSV, Seyed MN, Erika FM, Diana CSN, Maria D, Dirce FM. Fruit as potent natural antioxidants and their biological effects. Current pharmaceutical biotechnology. 2016; 17(11): 986-993 (8).
Pietta PG. Flavonoids as antioxidants. J. Nat. Prod. 2000; 63(7):1035-1042.
Njus D, Kelley PM, Tu YJ, Schlege HB. Ascorbic acid: The chemistry underlying its antioxidant properties. Elsevier 2020.
Chakrabothy A, Ramani P, Sherlin HJ, Premkumar P, Natesan A. Antioxidant and pro-oxidant activity of vitamin in the oral environment. IJDR. 2014; 25(4): 499-504.
Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahid F. The role of Vitamin E in human health and some diseases. Sultan. Qaboos. Univ. Med. J. 2014; 14(2): e157-e165.
Marin FR, Frutos MJ, Perez-Alvarez JA, Martinez-Sanchez F, Del Rio JA. Flavonoids as nutraceutical: structural related antioxidant properties and their role on ascorbic acid preservation. Stud. Nat. Prod. Chem. 2002: 26: 741-78.
Sheraz MA, Khan MF, Ahmed SO, Kazi SH, Ahmad IQ. Stability and stabilization of ascorbic acid. Househ. Pers. Care. Today. 2015; 0: 22-25.
Foyer CH. Ascorbic acid, Antioxidants in higher plants, CRC press. 2017: 31-58.
Hamidi NAM, Haris MS, Ismail AFH, Lestari W. Ascorbic acid-loaded poly (lactic-co-glycolic acid) nanoparticles incorporated into a polyacrylic acid gel as a promising tool for site-specific oral cancer therapy. Thai. J. Pharm. Sci. 2023; 46(6): 696-710.
Almubarak T, Almubarak M, Moajil AA, Alotaibi FM. Vitamin C: An environmentally friendly multifunctional additive for hydraulic fracturing fluids. 2022. 10.2118/211113-MS
Bajaj S, Singla D, Sakhuja N. Stability testing of pharmaceutical products. J. App. Pharm. Sci. 2012; 2(3): 129-138.
Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat. Rev. Drug. Discov. 2005; 4298-306.
Singh R. Current trends in forced degradation study for pharmaceutical product development. J Pharm Educ Res. 2012; 3(1): 324.
Alsante KM, Ando A, Brown R, Ensing J, Hatajik TD, Kong W, Tsuda Y. The role of degradant profling in active pharmaceutical ingredients and drug products. Adv Drug Deliv Rev 2007; 59(1): 29–37.
Blessy M, Patel RD, Prajapati PN, Agarwal YK. Development of forced degradation and stability indicating studies of drugs-A review. J. Pharm. Anal. 2014; 4(3): 159-165.
Iram F, Iram H, Iqbal A, Husain A. Forced degradation studies. J Anal Pharm Res. 2016; 3(6): 00073.
Reynolds DW, Facchine KL, Mullaney JF, Alsante KM, HatajikTD, Motto MG. Conducting forced degradation studies. Pharm Technol 2002; 26: 48–56.
Kats M. Forced degradation studies: regulatory considerations and implementation. BioPharma Int 2005; 18(7): 0–45.
Aguilar K, Garvin A, Lara-Sagahon AV, Ibarz A. Ascorbic acid degradation in aqueous solution during UV-Vis irradiation. Food Chemistry. 2019; 1:297: 124864.
Attia M, Essa EA, Zaki RM, Elkordy AA. An overview of the antioxidant efects of ascorbic acid and alpha lipoic acid (in liposomal forms) as adjuvant in cancer treatment. Antioxidants. 2022.
Li Y, Yang Y, Yu AN, Wang K. Effects of reaction parameters on self-degradation of L-ascorbic acid and self-degradation kinetics. Food science and biotechnology. 2016; 25: 97-104.
Goshima K, Maezono N, Tokuyama K. A novel degradation pathway of L-ascorbic acid under non-oxidative conditions. Bull. Chem. Soc. Jpn. 1973; 46: 902-904.
Herbig AL, Renard CM. Factors that impact the stability of vitamin C at intermediate temperatures in a food matrix. Food Chemistry 2017; 1: 220-444-51.
Sarturi GN, Robazza WS, Galvao AC. Dynamic study of ascorbic acid degradation in fresh juices of orange, lemon, and tangerine as a function of temperature: experimental data and kinetic modeling. In III International Symposium on medicinal and nutraceutical plants and III conference of the national institute of science and technology for tropical fruits. 2012; 14: 159-162 10.17660/Acta Horoom temperatureic. 2018. 1198.26
Pilarski B, Wyrzykowski D, Mlodzianowski J. A new approach for studying the stability and degradation products of ascorbic acid in solutions. J. Solution Chem. 2023; 13: 1-9.
Marfil PH, Santos EM, Telis VR. Ascorbic acid degradation kinetics in tomatoes at different drying conditions. LWT-Food Science and Technology. 2008; 1:41(9): 1642-1647.
Nasheed W, Qamar F. Degradation study of ascorbic acid by UV spectroscopy. IJCRCPS 2015; 2(2): 19-24
Avdeeva LV, Gvozdev RI. Oxidation of L-ascorbic acid in the presence of the copper-binding compound from methanotrophic bacteria methylococcuscapsulatus (M). Biometrics. 2020; 8:5(4):48.
Yuan JP, Chen F. Degradation of ascorbic acid in aqueous solution. J. Agri. Food Chem. 1998; 21:46(12), 5078-5082.
Tatum JH, Shaw PE, Berry RE. Degradation products from ascorbic acid. Journal of agricultural and food chemistry 1969; 17(1):38-40.
Guideline IHT. Impurities in new drug products. Q3B (R2), current step 2006; 4:1–16.
Guideline IHT. Validation of analytical procedure: text and methodology Q2(R1), current step 2005; 4:1–17
Guideline IHT. Stability testing of new drug substances and products Q1A(R2), current step 2003; 4:1–24.
Guideline IHT. Evaluation for stability data Q1E, current step 2003; 4:1–19.
Guideline IHT Photostability testing of new drug substances and products Q1B, current step 1996; 4:1–12.
Published
Abstract Display: 461 
PDF Downloads: 396 
